Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

A1. Novel Agents

Poster Session: Novel Agents

(P-1097) Efficacy of Rifaquizinone in a Murine Model of Prosthetic Joint Infection (PJI) with Fluoroquinolone-Sensitive and -Resistant Staphylococcus aureus

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
Location: Halls JK

    Presenting Author(s)

  • MP

    Mark E Pulse, MS

    Associate Director
    University of North Texas Health Science Center
    Fort Worth, Texas, United States

    • Co-Author(s)

  • PN

    Phung Nguyen, BS

    Research Investigator
    University of North Texas Health Science Center
    Fort Worth, Texas, United States

  • DV

    David Valtierra, Master

    HSC College of Pharmacy, University of North Texas
    Fort Worth, Texas, United States

  • KP

    Kelly Peterson, PhD

    HSC College of Pharmacy, University of North Texas
    Fort Worth, Texas, United States

  • Zhenkun Ma, PhD (he/him/his)

    CEO
    TenNor Therapeutics
    Suzhou Industrial Park, Jiangsu, China (People's Republic)

  • Huan Wang, PhD (she/her/hers)

    Director of pharmacology and toxicology
    TenNor Therapeutics (Suzhou) Ltd
    Suzhou, Jiangsu, China (People's Republic)

  • William J Weiss, MS

    Director
    University of North Texas Health Science Center
    Fort Worth, Texas, United States